title: Stress-induced priming of glutamate synapses unmasks associative short-term plasticity.
abstract: Exposure to a stressor sensitizes or 'primes' the hypothalamic-pituitary-adrenal axis to a subsequent novel stressor. The synaptic mechanisms underlying this priming, however, are not known. We found that exposing a rat to a single stressor primed glutamate synapses in the paraventricular nucleus of the hypothalamus and allowed them to undergo a short-term potentiation (STP) following a burst of high-frequency afferent activity. This transient potentiation requires a corticotrophin-releasing hormone-dependent depression of postsynaptic NMDA receptors (NMDARs). The long-term depression of NMDAR function after stress prevented the vesicular release of an inhibitory retrograde messenger that, in control conditions, arrests STP. Following stress, STP manifested as an increase in the release probability of glutamate that was sufficient to induce multivesicular release. Our findings indicate that the priming of synapses to express STP is a synaptic correlate to stress-induced behavioral and neuroendocrine sensitization.
authors.affiliation: Hotchkiss Brain Institute and Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada.
authors.forename: J Brent
authors.initials: JB
authors.lastname: Kuzmiski
authors.forename: Vincent
authors.initials: V
authors.lastname: Marty
authors.forename: Dinara V
authors.initials: DV
authors.lastname: Baimoukhametova
authors.forename: Jaideep S
authors.initials: JS
authors.lastname: Bains
mesh_terms: D000818:Animals; D055592:Biophysical Phenomena / Q000187:drug effects; D001703:Biophysics / Q000379:methods; D002614:Chelating Agents / Q000494:pharmacology; D003346:Corticotropin-Releasing Hormone / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D016291:Dizocilpine Maleate / Q000494:pharmacology; D004347:Drug Interactions; D004533:Egtazic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D004558:Electric Stimulation / Q000379:methods; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects; D005089:Exocytosis / Q000187:drug effects; D046352:Freezing Reaction, Cataleptic / Q000502:physiology; D018698:Glutamic Acid / Q000378:metabolism*; D066298:In Vitro Techniques; D008297:Male; D009473:Neuronal Plasticity / Q000187:drug effects / Q000502:physiology*; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D010286:Paraventricular Hypothalamic Nucleus / Q000166:cytology* / Q000378:metabolism; D018408:Patch-Clamp Techniques / Q000379:methods; D011743:Pyrimidines / Q000494:pharmacology; D011758:Pyrroles / Q000494:pharmacology; D011810:Quinoxalines / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D050600:SNARE Proteins / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology; D013312:Stress, Physiological / Q000502:physiology*; D013569:Synapses / Q000187:drug effects / Q000502:physiology*; D013997:Time Factors
chemical_list: C101628:CP 154526; D002614:Chelating Agents; D018691:Excitatory Amino Acid Antagonists; D011743:Pyrimidines; D011758:Pyrroles; D011810:Quinoxalines; D050600:SNARE Proteins; D018698:Glutamic Acid; D004533:Egtazic Acid; C056723:FG 9041; D016291:Dizocilpine Maleate; D003346:Corticotropin-Releasing Hormone; C025603:1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
references.citation: Nature. 2002 Jun 6;417(6889):649-53
references.pmid: 12050666
references.citation: Science. 2008 Apr 11;320(5873):201-5
references.pmid: 18403705
references.citation: Physiol Behav. 2004 Sep 30;82(4):751-62
references.pmid: 15327926
references.citation: Neurosci Biobehav Rev. 2008 Aug;32(6):1121-35
references.pmid: 18514314
references.citation: Drug Metab Dispos. 2002 Feb;30(2):173-6
references.pmid: 11792687
references.citation: Science. 1998 Jan 16;279(5349):399-403
references.pmid: 9430593
references.citation: Neuron. 2009 Jul 16;63(1):92-105
references.pmid: 19607795
references.citation: J Neurosci. 2010 Jan 6;30(1):242-54
references.pmid: 20053906
references.citation: Brain Res Mol Brain Res. 2000 Jan 10;75(1):166-71
references.pmid: 10648901
references.citation: Neuroscience. 1995 May;66(2):247-52
references.pmid: 7477869
references.citation: Mol Endocrinol. 1993 Oct;7(10):1357-67
references.pmid: 8264665
references.citation: Neuroendocrinology. 2004;80(4):252-63
references.pmid: 15627803
references.citation: J Neurosci. 2008 Mar 12;28(11):2903-11
references.pmid: 18337421
references.citation: Nat Neurosci. 2009 Apr;12(4):438-43
references.pmid: 19252497
references.citation: J Psychiatr Res. 2006 Feb;40(1):1-21
references.pmid: 16242154
references.citation: Nat Neurosci. 2005 Aug;8(8):1043-50
references.pmid: 16025109
references.citation: J Comp Neurol. 2008 Dec 1;511(4):479-96
references.pmid: 18853426
references.citation: Neuron. 2005 Feb 3;45(3):419-31
references.pmid: 15694328
references.citation: Neuron. 2006 Nov 22;52(4):663-77
references.pmid: 17114050
references.citation: Science. 1990 Nov 30;250(4985):1276-8
references.pmid: 1978759
references.citation: Eur J Pharmacol. 1989 May 19;164(2):257-63
references.pmid: 2547636
references.citation: Histochemistry. 1985;83(1):5-16
references.pmid: 3900007
references.citation: Cell. 2006 May 19;125(4):775-84
references.pmid: 16713567
references.citation: J Neurosci. 2008 Mar 12;28(11):2814-9
references.pmid: 18337411
references.citation: Science. 1999 Jun 11;284(5421):1811-6
references.pmid: 10364548
references.citation: Brain Res Mol Brain Res. 1994 Jul;24(1-4):192-8
references.pmid: 7968357
references.citation: Neuron. 2009 Jul 30;63(2):154-70
references.pmid: 19640475
references.citation: J Neurosci. 2002 May 1;22(9):3788-94
references.pmid: 11978854
references.citation: J Neuroendocrinol. 1998 Feb;10(2):119-31
references.pmid: 9535058
references.citation: Neuron. 2008 Aug 14;59(3):475-85
references.pmid: 18701072
references.citation: Neuron. 1991 Dec;7(6):971-84
references.pmid: 1684903
references.citation: Neuroendocrinology. 2000 Jun;71(6):354-65
references.pmid: 10878497
references.citation: Endocrinology. 2000 Dec;141(12):4801-4
references.pmid: 11108297
references.citation: J Neuroendocrinol. 2002 Dec;14(12):929-32
references.pmid: 12472873
references.citation: Endocrinology. 1996 Nov;137(11):4619-29
references.pmid: 8895325
references.citation: Philos Trans R Soc Lond B Biol Sci. 2009 Feb 12;364(1515):357-67
references.pmid: 18977732
references.citation: Eur J Pharmacol. 1998 Jul 3;352(1):65-71
references.pmid: 9718269
references.citation: Proc Natl Acad Sci U S A. 1985 May;82(10):3528-31
references.pmid: 2987931
references.citation: Neuron. 2001 Nov 20;32(4):673-82
references.pmid: 11719207
references.citation: J Neurosci. 2009 Jun 3;29(22):7349-58
references.pmid: 19494156
references.citation: Nature. 2002 Nov 28;420(6914):414-8
references.pmid: 12459783
references.citation: Brain Res. 2001 Jul 27;908(2):187-96
references.pmid: 11454329
references.citation: Neuroendocrinology. 1975;18(2):213-6
references.pmid: 170555
references.citation: Science. 1994 Sep 30;265(5181):2098-101
references.pmid: 7916485
references.citation: Neuroscience. 2004;126(3):533-40
references.pmid: 15183503
references.citation: Horm Behav. 2006 Nov;50(4):550-61
references.pmid: 16870185
references.citation: Drug Discov Today. 2010 May;15(9-10):371-83
references.pmid: 20206287
references.citation: Endocrinology. 2008 Mar;149(3):1389-98
references.pmid: 18079206
references.citation: J Comp Neurol. 1990 Apr 8;294(2):192-201
references.pmid: 2332527
references.citation: Nat Genet. 1998 Jun;19(2):162-6
references.pmid: 9620773